LKT Labs

Biochemicals for Life Science Research

Mdivi-1

Mdivi-1

Product ID M1335
Cas No. 338967-87-6
Purity ≥98%
Product Unit SizeCostQuantityStock
5 mg $76.00 In stock
25 mg $304.00 In stock
Bulk Quote

Quicklinks

Description

Mdivi-1 is a quinazolinone inhibitor of mitochondrial division that prevents mitochondrial fission and exhibits neuroprotective, cardioprotective, and anti-metastatic properties. In spinal cord injury models, Mdivi-1 decreases neuronal apoptosis and ameliorates motor dysfunction. In animal models of myocardial infarction, this compound decreases oxidative damage, enhances myocardial performance, and improves overall survival rates. Mdivi-1 also inhibits hypoxia-induced migration in breast cancer cells and improves the activity of other co-administered chemotherapeutics.

Product Info

Cas No.

338967-87-6
Purity

≥98%
Formula

C15H10Cl2N2O2S
Formula Wt.

353.2
Chemical Name

3-(2,4-Dichloro-5-methoxyphenyl)-2-sulfanyl-4(3H)-quinazolinone
IUPAC Name

3-(2,4-Dichloro-5-methoxyphenyl)-2-thioxo-2,3-dihydro-4(1H)-quinazolinone
Solubility

DMSO 70 mg/mL Water Insoluble Ethanol Insoluble

Shipping and Storage

Store Temp

-20°C
Ship Temp

Ambient

Downloads

MSDS

M1335 MSDS PDF
Info Sheet

M1335 Info Sheet PDF

References

Li G, Jia Z, Cao Y, et al. Mitochondrial Division Inhibitor 1 Ameliorates Mitochondrial Injury, Apoptosis, and Motor Dysfunction After Acute Spinal Cord Injury in Rats. Neurochem Res. 2015 May 13. [Epub ahead of print]. PMID: 25968480.

Liu JM, Yi Z, Liu SZ, et al. The mitochondrial division inhibitor mdivi-1 attenuates spinal cord ischemia-reperfusion injury both in vitro and in vivo: Involvement of BK channels. Brain Res. 2015 Mar 24. [Epub ahead of print]. PMID: 25818100.

Sharp WW, Beiser DG, Fang YH, et al. Inhibition of the mitochondrial fission protein dynamin-related protein 1 improves survival in a murine cardiac arrest model. Crit Care Med. 2015 Feb;43(2):e38-47. PMID: 25599491.

Han XJ, Yang ZJ, Jiang LP, et al. Mitochondrial dynamics regulates hypoxia-induced migration and antineoplastic activity of cisplatin in breast cancer cells. Int J Oncol. 2015 Feb;46(2):691-700. PMID: 25434519.

Custom Order

  • Size of single unit expressed as number (e.g. '500' in the case of 500 mg)
  • Total quantity of unit size desired (e.g. '10' in the case of 10 x 500 mg). If only one unit is desired, you may leave this blank.
  • This field is for validation purposes and should be left unchanged.

Related Products

  • L960006

    LY-2606368

    CHK1 inhibitor.

    ≥98%
  • K0652

    Kb NB 142-70

    PKD inhibitor.

    ≥98%
  • N344786

    N-Nitroso Valsartan Methyl Ester

    Valsartan impurity

    ≥98%
  • T0299

    Tazobactam Sodium

    β-lactamase inhibitor.

    ≥98%
  • L8010

    D-Luciferin Potassium

    Heterocyclic light-emitting compound, natural l...

    ≥98%
  • R3586

    Rivastigmine Tartrate

    AChE and BChE inhibitor.

    ≥99%
  • B8072

    3-tert-Butyl-5-Methoxycatechol

    BHA derivative, cellular differentiation induce...

    ≥95%
  • T0100

    10-Deacetyltaxol

    Taxane found in Taxus; microtubule depolymeriza...

    ≥98%
  • A5327

    Anagrelide

    Imidazoquinazoline; PDE3 inhibitor.

    ≥98%
  • C3246

    Cilostazol

    Quinoline; PDE 3B inhibitor.

    ≥98%
  • P7608

    PTC124

    Read-through agent and nonsense mutation target...

    ≥98%
  • C0250

    Calcitonin Gene Related Peptide II, human

    Calcitonin-family peptide, involved in vasodila...

    ≥95%
  • T3132

    Thiazovivin

    ROCK inhibitor.

    ≥98%
  • D023721

    Dasatinib

    Multikinase inhibitor.

    ≥99%
  • P2810

    Phenylbutazone

    NSAID; COX-1/2 inhibitor.

    ≥98%
  • D3320

    Difenoconazole

    Triazole; 14-α demethylase inhibitor, potentia...

    ≥98%
  • S1061

    Small Cardioactive Peptide B

    Peptide found in molluscs, cardiomodulator.

    ≥95%
  • P698583

    Prostaglandin E2

    principal metabolic product of COX-2

    ≥98%
  • M577521

    Monascorubrin

    Bulgarialactone azaphilone

    ≥98%
  • R0349

    Ramosetron

    5-HT3 antagonist.

    ≥99%